For more information, log on to: www.drreddys.comARICEPT ® is a trademark used by Eisai Inc. under license from Eisai R&D Management Co., Ltd.*IMS National Sales Perspectives: Retail and Non-Retail MAT May 2013
India drugmaker Intas will pay about $770 million for the UK and Ireland generics assets.
The generic-drug industry has undergone a flurry of acquisition activity over the past 18 months, highlighted by the long-anticipated but only recent closing of Teva Pharmaceutical's purchase of Allergan's generics.
Trade-Ideas LLC identified Dr Reddy's Laboratories (RDY) as a weak on high relative volume candidate
GLV GLO RDY are going ex-dividend tomorrow, Thursday, July 14, 2016